|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date16 Nov 2020 |
|
Mechanism30S subunit inhibitors [+3] |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Sonoran Biosciences, Inc.
0 Patents (Medical) associated with Sonoran Biosciences, Inc.
100 Deals associated with Sonoran Biosciences, Inc.
100 Translational Medicine associated with Sonoran Biosciences, Inc.